Johnson & Johnson received unfavorable news for the company on Tuesday, June 1, after the Supreme Court rejected its appeal for the cancellation of a court decision where it was ordered to pay $2.1 billion in penalty.
The case against Johnson & Johnson is about the allegations the asbestos in its talc powder caused cancer in women, specifically many have reportedly developed ovarian cancer. The talc powder products also include the baby powder that has been around since 1893.
The Supreme Court upheld the penalty order
The high court announced without any kind of argument that it will not hear the case thus the penalty will not be scrapped. According to the order, Justices Samuel Alito and Brett Kavanaugh recused or disqualified themselves from consideration of the case.
CNBC reported that Johnson & Johnson made a request for the Supreme Court to assess the penalty it received after the amount was sustained by the Missouri Supreme Court in 2020. Although the amount is high, this was already reduced from the initial $4 billion.
The company that develops medical devices, pharmaceuticals and consumer packaged goods stated it is facing over 21,000 lawsuits for the talc products. Thus, in May 2020, Johnson & Johnson shared that it has already halted the selling of talc-based baby powder in Canada and the United States.
The company cited lower demand for the said item due to the spread of misinformation concerning the talc powders’ safety. It added the legal cases have also negatively affected the brand.
J&J’s response to the decision
In any case, J&J’s appeal for the Supreme Court to review its penalty was turned down and the opponent’s lawyer’s argument played a role. Ken Starr, a former Whitewater prosecutor who is representing the women who sued Johnson & Johnson, wrote in his brief that the justices should not review the case because, for decades, the company has been aware that their talc powders are made with asbestos as one of its ingredients. The substance is said to be “highly carcinogenic with no known safe exposure level.”
Finally, Reuters reported that J&J said the decision left unresolved legal issues and maintained that its baby powder is safe. The company reiterated there are scientific evaluations that prove the “product is safe, does not contain asbestos, and does not cause cancer."


Asian Stock Markets Start New Year Higher as Tech and AI Shares Drive Gains
Forex Markets Hold Steady as Traders Await Fed Minutes Amid Thin Year-End Volumes
U.S. Stock Index Futures Steady as Markets Await Fed Policy Clues in Holiday-Thinned Trade
China Manufacturing PMI Rebounds in December, Offering Boost to Economic Growth Outlook
Anthropic Raises 2026 Revenue Outlook by 20% but Delays Path to Profitability
California Governor Gavin Newsom Launches Review Into Alleged TikTok Content Suppression After U.S. Ownership Deal
South Korean Won Slides Despite Government Efforts to Stabilize Currency Markets
Citi Forecasts a Volatile but Ongoing Bull Market for S&P 500 in 2026
LVMH Investors Watch Earnings Closely as Luxury Recovery Faces New Challenges
BYD and Exxon Mobil Strengthen Hybrid Technology Partnership
Microsoft Wins Approval to Build 15 New Data Centers in Wisconsin
South Korea Factory Activity Returns to Growth in December on Export Rebound
The Maire - EuroChem Case: Three Lessons for Global Business
USDA $12 Billion Farm Aid Program Draws Mixed Reactions from Row Crop Farmers
ASML’s EUV Lithography Machines Power Europe’s Most Valuable Tech Company
Wall Street Ends Mixed as Tech and Financial Stocks Weigh on Markets Amid Thin Holiday Trading
Alibaba-Backed Moonshot AI Unveils Kimi K2.5 to Challenge China’s AI Rivals 



